FDA IND Approval for Phase 3 Study of DMX-200 in FSGS

• FDA IND approved for ACTION3 Phase 3 clinical study, paving the way for patient recruitment in the United States • United States is one of 12 countries to recruit patients for Part 1 of the ACTION3 clinical study 1 The trial is being conducted at 75 sites across 12 countries, with 19 of those sites in the US All activated sites are proactively screening for suitable patients The study has 2 inte